Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triflusal on cognitive functions in healthy participants
NCT02321852Phase 2Completed
- Start
- Jan 2015
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Triflusal in cognitive impairment. Started Jan 2015; status: completed.
02
Drugs
Triflusal
03
Conditions
cognitive impairment
Beyond the preview
Go deeper on NCT02321852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02321852.